Compare INCY & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INCY | PNFP |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | 3709 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 14.9B |
| IPO Year | 1994 | N/A |
| Metric | INCY | PNFP |
|---|---|---|
| Price | $117.62 | $102.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 17 |
| Target Price | $103.52 | ★ $113.31 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | ★ 4173.33 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $3,394,635,000.00 | N/A |
| Revenue This Year | $10.44 | $160.52 |
| Revenue Next Year | $10.99 | $9.24 |
| P/E Ratio | $79.38 | ★ $12.24 |
| Revenue Growth | ★ 13.67 | N/A |
| 52 Week Low | $69.70 | $81.08 |
| 52 Week High | $119.60 | $107.00 |
| Indicator | INCY | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 62.08 | 56.89 |
| Support Level | $98.50 | $92.68 |
| Resistance Level | $119.29 | $107.00 |
| Average True Range (ATR) | 3.08 | 2.68 |
| MACD | -0.45 | -0.21 |
| Stochastic Oscillator | 80.75 | 77.24 |
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.